Detalhe da pesquisa
1.
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking.
Oncology
; 101(4): 252-256, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538910
2.
Immune escape mechanisms in head and neck squamous cell carcinoma and implication for new immunotherapy approach.
Curr Opin Oncol
; 32(3): 203-209, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32195680
3.
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).
Oncology
; 98(11): 763-770, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32629446
4.
Expression and subcellular localization of the bromodomain-containing protein 7 is a prognostic biomarker in breast cancer.
Anticancer Drugs
; 31(4): 423-430, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31929348
5.
Lenvatinib Long-Term Responses in Refractory Thyroid Cancer: Our Mono-Institutional Real-Life Experience with the Multidisciplinary Approach and Review of Literature.
Oncology
; 97(4): 206-210, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390629
6.
Melanoma: the new perspectives from clinical and translational research.
Anticancer Drugs
; 30(6): 543-553, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31021826
7.
Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma.
Oncology
; 95(4): 202-210, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29975952
8.
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.
Future Oncol
; 14(14): 1347-1354, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29774766
9.
MicroRNAs role as potential biomarkers and key regulators in melanoma.
Genes Chromosomes Cancer
; 56(1): 3-10, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27561079
10.
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy.
Cancer Immunol Immunother
; 66(5): 573-579, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28197666
11.
Eribulin in advanced breast cancer: safety, efficacy and new perspectives.
Future Oncol
; 13(30): 2759-2769, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29219017
12.
Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.
Oncologist
; 21(1): 59-71, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712958
13.
Schedule-dependent interaction between temsirolimus and cetuximab in head and neck cancer: a preclinical study.
Anticancer Drugs
; 27(6): 533-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26982238
14.
Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.
Lancet Oncol
; 16(2): 208-20, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596660
15.
The effect of paclitaxel and nab-paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines.
Invest New Drugs
; 33(4): 801-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25947567
16.
Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines.
Invest New Drugs
; 33(2): 310-20, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25603975
17.
Real-world study of everolimus in advanced progressive neuroendocrine tumors.
Oncologist
; 19(9): 966-74, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117065
18.
State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013.
Oncology
; 86(4): 212-29, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24820548
19.
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
J Immunother Cancer
; 12(1)2024 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290766
20.
Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database.
Eur J Cancer
; 203: 114038, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38579517